1)Hashiguchi Y, Muro K, Saito Y, et al:Japanese Society for Cancer of the Colon and Rectum(JSCCR)guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1-42, 2020
2)Yamada K, Saiki Y, Komori K, et al:Characteristics of anal canal cancer in Japan. Cancer Med. 2022 Mar 10〔Online ahead of print〕
3)NCCN clinical practice Guideline in Oncology肛門癌 ver.1, 2022
4)Steele SR, Varma MG, Melton GB, et al:Practice parameters for anal squamous neoplasms. Dis Colon Rectum 55:735-749, 2012
5)Uronis HE, Bendell JC:Anal cancer:an overview. Oncologist 12:524-534, 2007
6)Alemany L, Saunier M, Alvarado-Cabrero I,et al:Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 136:98-107, 2015
7)Edge SB, Byrd DR, Compton CC, et al(ed):AJCC Cancer Staging Manual(de 8th Edition). New York, Springer, 2017
8)Ryan DP, Compton CC, Mayer RJ:Carcinoma of the anal canal. N Engl J Med 342:792-800, 2000
9)Costas-Chavarri A, Nandakumar G, Temin S, et al:Treatment of Patients With Early-Stage Colorectal Cancer:ASCO Resource-Stratified Guideline. J Glob Oncol 5:1-19, 2019
10)Northover J, Glynne-Jones R, Sebag-Montefiore D, et al:Chemoradiation for the treatment of epidermoid anal cancer:13-year follow-up of the first randomised UKCCCR Anal Cancer Trial(ACT I). Br J Cancer 102:1123-1128, 2010
11)Cummings BJ:Metastatic anal cancer:the search for cure. Onkologie 29:5-6, 2006
12)Rao S, Sclafani F, Eng C, et al:International Rare Cancers Initiative Multicenter Randomized Phase Ⅱ Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer:InterAAct. J Clin Oncol 38:2510-2518, 2020
13)Mondaca S, Chatila WK, Bates D, et al:FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer. Clin Colorectal Cancer 18:e39-e52, 2019
14)Sousa TT, Santos BD, Belotto M, et al:Successful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case report. J Gastrointest Oncol 7:E103-E106, 2016
15)Kim S, François E, André T, et al:Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma(Epitopes-HPV02):a multicentre, single-arm, phase 2 study. Lancet Oncol 19:1094-1106, 2018
16)Renehan AG, Saunders MP, Schofield PF, et al:Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 92:605-614, 2005